Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509654101> ?p ?o ?g. }
- W2509654101 endingPage "2597" @default.
- W2509654101 startingPage "2575" @default.
- W2509654101 abstract "Corticosteroids are effective in the management of a variety of disease states, such as several forms of neoplasia (leukemia and lymphoma), autoimmune conditions, and severe inflammatory responses. Molecular strategies that selectively target delivery of corticosteroids minimize or prevents large amounts of the pharmaceutical moiety from passively diffusing into normal healthy cell populations residing within tissues and organ systems.The covalent immunopharmaceutical, dexamethasone-(C21-phosphoramide)-[anti-EGFR] was synthesized by reacting dexamethasone-21-monophosphate with a carbodiimide reagent to form a dexamethasone phosphate carbodiimide ester that was subsequently reacted with imidazole to create an amine-reactive dexamethasone-(C21-phosphorylimidazolide) intermediate. Monoclonal anti-EGFR immunoglobulin was combined with the amine-reactive dexamethasone-(C21-phosphorylimidazolide) intermediate, resulting in the synthesis of the covalent immunopharmaceutical, dexamethasone-(C21-phosphoramide)-[anti-EGFR]. Following spectrophotometric analysis and validation of retained epidermal growth factor receptor type 1 (EGFR)-binding avidity by cell-ELISA, the selective anti-neoplasic cytotoxic potency of dexamethasone-(C21-phosphoramide)-[anti-EGFR] was established by MTT-based vitality stain methodology using adherent monolayer populations of human pulmonary adenocarcinoma (A549) known to overexpress the tropic membrane receptors EGFR and insulin-like growth factor receptor type 1.The dexamethasone:IgG molar-incorporation-index for dexamethasone-(C21-phosphoramide)-[anti-EGFR] was 6.95:1 following exhaustive serial microfiltration. Cytotoxicity analysis: covalent bonding of dexamethasone to monoclonal anti-EGFR immunoglobulin did not significantly modify the ex vivo antineoplastic cytotoxicity of dexamethasone against pulmonary adenocarcinoma at and between the standardized dexamethasone equivalent concentrations of 10(-9) M and 10(-5) M. Rapid increases in antineoplastic cytotoxicity were observed at and between the dexamethasone equivalent concentrations of 10(-9) M and 10(-7) M where cancer cell death increased from 7.7% to a maximum of 64.9% (92.3%-35.1% residual survival), respectively, which closely paralleled values for free noncovalently bound dexamethasone.Organic chemistry reaction regimens were optimized to develop a multiphase synthesis regimen for dexamethasone-(C21-phosphoramide)-[anti-EGFR]. Attributes of dexamethasone-(C21-phosphoramide)-[anti-EGFR] include a high dexamethasone molar incorporation-index, lack of extraneous chemical group introduction, retained EGFR-binding avidity (targeted delivery properties), and potential to enhance long-term pharmaceutical moiety effectiveness." @default.
- W2509654101 created "2016-09-16" @default.
- W2509654101 creator A5055103291 @default.
- W2509654101 creator A5078503950 @default.
- W2509654101 date "2016-08-01" @default.
- W2509654101 modified "2023-09-25" @default.
- W2509654101 title "Dexamethasone-(C<sub>21</sub>-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)" @default.
- W2509654101 cites W10899603 @default.
- W2509654101 cites W117619303 @default.
- W2509654101 cites W120506809 @default.
- W2509654101 cites W1495694210 @default.
- W2509654101 cites W1506708771 @default.
- W2509654101 cites W1507649522 @default.
- W2509654101 cites W1509399351 @default.
- W2509654101 cites W1519844196 @default.
- W2509654101 cites W1546284665 @default.
- W2509654101 cites W1552611029 @default.
- W2509654101 cites W181792704 @default.
- W2509654101 cites W1849819493 @default.
- W2509654101 cites W1886907949 @default.
- W2509654101 cites W1892490761 @default.
- W2509654101 cites W1894661133 @default.
- W2509654101 cites W1922227368 @default.
- W2509654101 cites W1963586152 @default.
- W2509654101 cites W1964056042 @default.
- W2509654101 cites W1964205716 @default.
- W2509654101 cites W1964752664 @default.
- W2509654101 cites W1965903551 @default.
- W2509654101 cites W1966937303 @default.
- W2509654101 cites W1970728828 @default.
- W2509654101 cites W1974113855 @default.
- W2509654101 cites W1974825648 @default.
- W2509654101 cites W1975106516 @default.
- W2509654101 cites W1976070015 @default.
- W2509654101 cites W1977680059 @default.
- W2509654101 cites W1978089940 @default.
- W2509654101 cites W1980211974 @default.
- W2509654101 cites W1981429758 @default.
- W2509654101 cites W1981904605 @default.
- W2509654101 cites W1984007340 @default.
- W2509654101 cites W1984125420 @default.
- W2509654101 cites W1985278916 @default.
- W2509654101 cites W1990019369 @default.
- W2509654101 cites W1990563512 @default.
- W2509654101 cites W1991404956 @default.
- W2509654101 cites W1994034291 @default.
- W2509654101 cites W1997104432 @default.
- W2509654101 cites W1997782547 @default.
- W2509654101 cites W2000302977 @default.
- W2509654101 cites W2003893312 @default.
- W2509654101 cites W2004248864 @default.
- W2509654101 cites W2004933618 @default.
- W2509654101 cites W2007511662 @default.
- W2509654101 cites W2008173472 @default.
- W2509654101 cites W2008606387 @default.
- W2509654101 cites W2009909078 @default.
- W2509654101 cites W2010329820 @default.
- W2509654101 cites W2010450410 @default.
- W2509654101 cites W2012780399 @default.
- W2509654101 cites W2018019307 @default.
- W2509654101 cites W2018564354 @default.
- W2509654101 cites W2019154970 @default.
- W2509654101 cites W2019895529 @default.
- W2509654101 cites W2023499500 @default.
- W2509654101 cites W2024306921 @default.
- W2509654101 cites W2024520647 @default.
- W2509654101 cites W2024547239 @default.
- W2509654101 cites W2030971033 @default.
- W2509654101 cites W2031309834 @default.
- W2509654101 cites W2031924013 @default.
- W2509654101 cites W2032854578 @default.
- W2509654101 cites W2032919629 @default.
- W2509654101 cites W2034568070 @default.
- W2509654101 cites W2034599887 @default.
- W2509654101 cites W2036599257 @default.
- W2509654101 cites W2037041572 @default.
- W2509654101 cites W2037192290 @default.
- W2509654101 cites W2038173563 @default.
- W2509654101 cites W2038386885 @default.
- W2509654101 cites W2038717222 @default.
- W2509654101 cites W2040426470 @default.
- W2509654101 cites W2041365313 @default.
- W2509654101 cites W2043449526 @default.
- W2509654101 cites W2043681896 @default.
- W2509654101 cites W2044149959 @default.
- W2509654101 cites W2045432050 @default.
- W2509654101 cites W2045676262 @default.
- W2509654101 cites W2046208062 @default.
- W2509654101 cites W2046728338 @default.
- W2509654101 cites W2047602696 @default.
- W2509654101 cites W2051286967 @default.
- W2509654101 cites W2051636537 @default.
- W2509654101 cites W2052428534 @default.
- W2509654101 cites W2052428625 @default.
- W2509654101 cites W2053410918 @default.
- W2509654101 cites W2054729270 @default.
- W2509654101 cites W2055178552 @default.
- W2509654101 cites W2055214129 @default.